BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Aug 16, 2026; 18(8): 122124
Published online Aug 16, 2026. doi: 10.4253/wjge.122124
Table 1 Baseline of enrolled patients, n (%)

All
CR
Non-CR
P value
Total14535110
Sex0.633
    Male100 (69.0)23 (65.7)77 (70.0)
    Female45 (31.0)12 (34.3)33 (30.0)
Age, median (IQR), year58 (51.5-65.5)56 (51-65)58 (51.3-66)0.65
Location0.035
    Proximal34 (23.4)3 (8.6)31 (28.2)
    Middle80 (55.2)21 (60.0)59 (53.6)
    Distal31 (21.4)11 (31.4)20 (18.2)
Histology0.801
    Well/moderate125 (85.5)31 (88.6)93 (84.5)
    Poor17 (11.7)3 (8.6)14 (12.7)
    Special4 (2.8)1 (2.9)3 (2.7)
cT< 0.001
    cT211 (7.6)8 (22.9)3 (2.7)
    cT383 (57.2)23 (65.7)60 (54.5)
    cT451 (35.2)4 (11.4)47 (42.7)
cN0.361
    cN022 (15.2)7 (20.0)15 (13.6)
    cN+123 (84.8)28 (80.0)95 (86.4)
cM1
    cM0141 (97.2)34 (97.1)107 (97.3)
    cM+4 (2.8)1 (2.9)3 (2.7)
Pre-nCRT level of CEA, median (IQR), ng/mL4.84 (2.48-12.59)2.72 (1.74-9.15)5.5 (2.64-15.04)0.019
Post-nCRT level of CEA, median (IQR), ng/mL2.42 (1.57-4.14)2.28 (1.54-3.54)2.49 (1.57-4.42)0.32
Interval C/RT to endoscopy, median (IQR), weeks9 (7-10)9 (7-11)8 (7-10)0.207
Interval endoscopy to surgery, median (IQR), weeks13 (2-5)5 (2-6)3 (2-5)0.094


Write to the Help Desk